Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. Horizon's global headquarters are in Dublin, Ireland.
The Company also has offices in Lake Forest, Ill.; Chicago, Ill.; Brisbane, Calif.; Reinach, Switzerland and Mannheim, Germany.
Copyright Nasdaq. Minimum 15 minutes delayed.
Aug 7, 2017 at 8:00 AM EDT
Horizon Pharma Second Quarter 2017 Earnings Call
Jun 21, 2017 at 1:30 PM EDT
The JMP Securities Life Science Conference
Jun 6, 2017 at 11:30 AM EDT
Jefferies 2017 Global Healthcare Conference
May 8, 2017 at 7:30 AM EDT
Horizon Pharma First Quarter 2017 Earnings Call
May 8, 2017
Horizon Pharma plc Announces Agreement to Acquire River Vision Development Corp. and Teprotumumab (RV001), a Biologic in Late-Stage Development for Rare Eye Disease